Patents by Inventor Sunil M. Kurian

Sunil M. Kurian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230374595
    Abstract: By a genome-wide gene analysis of expression profiles of over 50,000 known or putative gene sequences in peripheral blood, the present inventors have identified a consensus set of gene expression-based molecular biomarkers associated with chronic allograft nephropathy and/or interstitial fibrosis and tubular atrophy CAN/IFTA and subtypes thereof. These genes sets are useful for diagnosis, prognosis, monitoring and/or subtyping of CAN/IFTA.
    Type: Application
    Filed: May 25, 2023
    Publication date: November 23, 2023
    Inventors: Daniel R. Salomon, Sunil M. Kurian, Steven R. Head
  • Patent number: 11821037
    Abstract: By a genome-wide gene analysis of expression profiles of over 50,000 known or putative gene sequences in peripheral blood, the present inventors have identified a consensus set of gene expression-based molecular biomarkers associated with chronic allograft nephropathy and/or interstitial fibrosis and tubular atrophy CAN/IFTA and subtypes thereof. These genes sets are useful for diagnosis, prognosis, monitoring and/or subtyping of CAN/IFTA.
    Type: Grant
    Filed: February 27, 2020
    Date of Patent: November 21, 2023
    Assignee: THE SCRIPPS RESEARCH INSTITUTE
    Inventors: Daniel R. Salomon, Sunil M. Kurian, Steven R. Head
  • Publication number: 20210230697
    Abstract: This disclosure provides methods of detecting sub-acute rejection and other categories of rejection in kidney transplant recipients using unique sets of gene expression markers.
    Type: Application
    Filed: May 10, 2019
    Publication date: July 29, 2021
    Inventors: Sunil M. Kurian, Michael M. Abecassis, John J. Friedewald
  • Publication number: 20200399700
    Abstract: By a genome-wide gene analysis of expression profiles of over 50,000 known or putative gene sequences in peripheral blood, the present inventors have identified a consensus set of gene expression-based molecular biomarkers associated with chronic allograft nephropathy and/or interstitial fibrosis and tubular atrophy CAN/IFTA and subtypes thereof. These genes sets are useful for diagnosis, prognosis, monitoring and/or subtyping of CAN/IFTA.
    Type: Application
    Filed: February 27, 2020
    Publication date: December 24, 2020
    Inventors: Daniel R. Salomon, Sunil M. Kurian, Steven R. Head
  • Patent number: 10870888
    Abstract: Disclosed herein are methods of detecting, predicting or monitoring a status or outcome of a transplant in a transplant recipient.
    Type: Grant
    Filed: February 17, 2018
    Date of Patent: December 22, 2020
    Assignees: The Scripps Research Institute, Northwestern University
    Inventors: Daniel Salomon, Sunil M. Kurian, Steven Head, Michael M. Abecassis, John J. Friedewald, Josh Levitsky
  • Publication number: 20190032135
    Abstract: By a genome-wide gene analysis of expression profiles of over 50,000 known or putative gene sequences in peripheral blood, the present inventors have identified a consensus set of gene expression-based molecular biomarkers associated with chronic allograft nephropathy and/or interstitial fibrosis and tubular atrophy CAN/IFTA and subtypes thereof. These genes sets are useful for diagnosis, prognosis, monitoring and/or subtyping of CAN/IFTA.
    Type: Application
    Filed: August 2, 2017
    Publication date: January 31, 2019
    Inventors: Daniel R. Salomon, Sunil M. Kurian, Steven R. Head
  • Publication number: 20180371546
    Abstract: Disclosed herein are methods of detecting, predicting or monitoring a status or outcome of a transplant in a transplant recipient.
    Type: Application
    Filed: February 17, 2018
    Publication date: December 27, 2018
    Inventors: Daniel Salomon, Sunil M. KURIAN, Steven HEAD, Michael M. ABECASSIS, John J. FRIEDEWALD, Josh LEVITSKY
  • Patent number: 9752191
    Abstract: By a genome-wide gene analysis of expression profiles of over 50,000 known or putative gene sequences in peripheral blood, the present inventors have identified a consensus set of gene expression-based molecular biomarkers associated with chronic allograft nephropathy and/or interstitial fibrosis and tubular atrophy CAN/IFTA and subtypes thereof. These genes sets are useful for diagnosis, prognosis, monitoring and/or subtyping of CAN/IFTA.
    Type: Grant
    Filed: July 9, 2010
    Date of Patent: September 5, 2017
    Assignee: The Scripps Research Institute
    Inventors: Daniel Salomon, Sunil M. Kurian, Steven R. Head
  • Publication number: 20150167085
    Abstract: Disclosed herein are methods of detecting, predicting or monitoring a status or outcome of a transplant in a transplant recipient.
    Type: Application
    Filed: September 9, 2014
    Publication date: June 18, 2015
    Inventors: Daniel R. Salomon, Sunil M. Kurian, Steven Head, Michael M. Abecassis, John J. Friedewald, Josh Levitsky
  • Publication number: 20120178642
    Abstract: By a genome-wide gene analysis of expression profiles of over 50,000 known or putative gene sequences in peripheral blood, the present inventors have identified a consensus set of gene expression-based molecular biomarkers associated with chronic allograft nephropathy and/or interstitial fibrosis and tubular atrophy CAN/IFTA and subtypes thereof. These genes sets are useful for diagnosis, prognosis, monitoring and/or subtyping of CAN/IFTA.
    Type: Application
    Filed: July 9, 2010
    Publication date: July 12, 2012
    Applicant: The Scripps Research Institute
    Inventors: Daniel Salomon, Sunil M. Kurian, Steven R. Head